<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Cytoplasmic+and+Nuclear%2Fbiosynthesis%2F%2Agenetics%2Fmetabolism&amp;sort_field=added&amp;sort_dir=a&amp;output=omeka-xml" accessDate="2026-04-13T06:34:30-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="4854" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="60492">
              <text>&lt;a href="http://doi.org/10.1186/s12929-015-0133-3" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.1186/s12929-015-0133-3&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="60494">
              <text>30–30</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="60495">
              <text>22</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="60484">
                <text>The orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="60485">
                <text>Journal of biomedical science</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="60486">
                <text>2015</text>
              </elementText>
              <elementText elementTextId="60487">
                <text>2015-05</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="60488">
                <text>Animals; Bile Acids and Salts/metabolism; Cytoplasmic and Nuclear/biosynthesis/*genetics/metabolism; Diabetes Mellitus/*drug therapy/genetics/metabolism; Gene Expression Regulation/drug effects; Glucose/metabolism; Hepatocytes/drug effects; Humans; Insulin Resistance/genetics; Insulin/*metabolism; Leptin/deficiency/genetics; Lipid Metabolism/drug effects; Messenger/genetics; Mice; Obese; PPAR gamma/*biosynthesis/genetics; Receptors; RNA; Thiazolidinediones/*administration &amp; dosage</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="60489">
                <text>Tseng Hsiu-Ting; Park Young Joo; Lee Yoon-Kwang; Moore David D</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="60490">
                <text>BACKGROUND: Small heterodimer partner (SHP, NR0B2) is involved in diverse metabolic pathways, including hepatic bile acid, lipid and glucose homeostasis, and has been implicated in effects on the peroxisome proliferator-activated receptor gamma (PPARgamma), a master regulator of adipogenesis and the receptor for antidiabetic drugs thiazolidinediones (TZDs). In this study, we aim to investigate the role of SHP in TZD response by comparing TZD-treated leptin-deficient (ob/ob) and leptin-, SHP-deficient (ob/ob;Shp(-/-)) double mutant mice. RESULTS: Both ob/ob and double mutant ob/ob;Shp(-/-) mice developed hyperglycemia, insulin resistance, and hyperlipidemia, but hepatic fat accumulation was decreased in the double mutant ob/ob;Shp(-/-) mice. PPARgamma2 mRNA levels were markedly lower in ob/ob;Shp(-/-) liver and decreased to a lesser extent in adipose tissue. The TZD troglitazone did not reduce glucose or circulating triglyceride levels in ob/ob;Shp(-/-) mice. Expression of the adipocytokines, such as adiponectin and resistin, was not stimulated by troglitazone treatment. Expression of hepatic lipogenic genes was also reduced in ob/ob;Shp(-/-) mice. Moreover, overexpression of SHP by adenovirus infection increased PPARgamma2 mRNA levels in mouse primary hepatocytes. CONCLUSIONS: Our results suggest that SHP is required for both antidiabetic and hypolipidemic effects of TZDs in ob/ob mice through regulation of PPARgamma expression.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="60491">
                <text>&lt;a href="http://doi.org/10.1186/s12929-015-0133-3" target="_blank" rel="noreferrer noopener"&gt;10.1186/s12929-015-0133-3&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="60493">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="250">
        <name>2015</name>
      </tag>
      <tag tagId="123">
        <name>Animals</name>
      </tag>
      <tag tagId="1390">
        <name>Bile Acids and Salts/metabolism</name>
      </tag>
      <tag tagId="28061">
        <name>Cytoplasmic and Nuclear/biosynthesis/*genetics/metabolism</name>
      </tag>
      <tag tagId="32956">
        <name>Department of Integrative Medical Sciences</name>
      </tag>
      <tag tagId="28062">
        <name>Diabetes Mellitus/*drug therapy/genetics/metabolism</name>
      </tag>
      <tag tagId="2261">
        <name>Gene Expression Regulation/drug effects</name>
      </tag>
      <tag tagId="1514">
        <name>Glucose/metabolism</name>
      </tag>
      <tag tagId="1440">
        <name>Hepatocytes/drug effects</name>
      </tag>
      <tag tagId="8">
        <name>Humans</name>
      </tag>
      <tag tagId="16198">
        <name>Insulin Resistance/genetics</name>
      </tag>
      <tag tagId="25504">
        <name>Insulin/*metabolism</name>
      </tag>
      <tag tagId="2899">
        <name>Journal of biomedical science</name>
      </tag>
      <tag tagId="21603">
        <name>Lee Yoon-Kwang</name>
      </tag>
      <tag tagId="16199">
        <name>Leptin/deficiency/genetics</name>
      </tag>
      <tag tagId="5638">
        <name>Lipid Metabolism/drug effects</name>
      </tag>
      <tag tagId="4815">
        <name>Messenger/genetics</name>
      </tag>
      <tag tagId="861">
        <name>Mice</name>
      </tag>
      <tag tagId="1488">
        <name>Moore David D</name>
      </tag>
      <tag tagId="32953">
        <name>NEOMED College of Medicine</name>
      </tag>
      <tag tagId="7681">
        <name>Obese</name>
      </tag>
      <tag tagId="5565">
        <name>Park Young Joo</name>
      </tag>
      <tag tagId="28063">
        <name>PPAR gamma/*biosynthesis/genetics</name>
      </tag>
      <tag tagId="551">
        <name>Receptors</name>
      </tag>
      <tag tagId="1131">
        <name>RNA</name>
      </tag>
      <tag tagId="28064">
        <name>Thiazolidinediones/*administration &amp; dosage</name>
      </tag>
      <tag tagId="16203">
        <name>Tseng Hsiu-Ting</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
